Paul I. Nadler

Genetic Alterations in the Gene Encoding the Major Hbsag: Dna and Immunological Analysis of Recurrent Hbsag Derived From Monoclonal Antibody—Treated Liver Transplant Patients

Gerald McMahon, Paul H. Ehrlich, Zeinab A. Moustafa et al. · Hepatology · 1992 · 180 citations · Full text

Life Sciences, Immunology, Molecular Biology +15

Efficacy of Sym004 in Patients With Metastatic Colorectal Cancer With Acquired Resistance to Anti-EGFR Therapy and Molecularly Selected by Circulating Tumor DNA Analyses

Clara Montagut, Guillem Argilés, Fortunato Ciardiello et al. · JAMA Oncology · 2018 · 144 citations · Full text

Medicine, Oncology, Pharmacology +17

Interferon kinetics and adverse reactions after intravenous, intramuscular, and subcutaneous injection

Robert J. Wills, Susana Dennis, Herbert E. Spiegel et al. · Clinical Pharmacology & Therapeutics · 1984 · 115 citations

Pharmacy, Pharmacokinetics, Pharmacology +17

Final results of a phase Ib dose-escalation study of PRI-724, a CBP/beta-catenin modulator, plus gemcitabine (GEM) in patients with advanced pancreatic adenocarcinoma (APC) as second-line therapy after FOLFIRINOX or FOLFOX.

Andrew H. Ko, E. Gabriela Chiorean, Eunice L. Kwak et al. · Journal of Clinical Oncology · 2016 · 69 citations

Medicine, Oncology, Pharmacology +15

T cell recognition in the mixed lymphocyte response. I. Non-T, radiation-resistant splenic adherent cells are the predominant stimulators in the murine mixed lymphocyte reaction.

Gerald B. Ahmann, Paul I. Nadler, Alan Birnkrant et al. · PubMed · 1979 · 49 citations

Life Sciences, Cell Biology, Immunology +13